1230-7483

Roadside inspections, traffic events and traffic accidents from 2010–2022 in the experience of the Institute of Forensic Research as a consulting body in light of the proposed thresholds for the states of ‘after use’ and ‘under the influence’ for THC

Kontrole, zdarzenia i wypadki drogowe z lat 2010–2022 w praktyce opiniodawczej Instytutu Ekspertyz Sądowych w świetle propozycji progów „po użyciu” i „pod wpływem” THC

Gieroń

Joanna

author

Instytut Ekspertyz Sądowych im. Prof. dra Jana Sehna w Krakowie

Correspondence to: Joanna Gieroń jgieron@ies.gov.pl

08 05 2024

136 2023 341 354

2024

<div>Road traffic safety depends largely on the psychophysical fitness of drivers. Apart from ethyl alcohol, this efficiency is influenced by many other factors, including: presence in the blood of the so-called substances that act similarly to alcohol, and cannabinols constitute one of the most popular groups of these substances. The paper presents statistics on delta-9-tetrahydrocannabinol (THC) – the main psychoactive ingredient of cannabis detected in the blood of drivers subjected to 7269 road inspections and involved in 4697 road events and accidents in the years 2010–2022 throughout Poland. Based on the results obtained, it was found that THC is present in the blood of 25–61% of roadside inspection cases, and in the case of road incidents and accidents, 5–15% of drivers have THC in a concentration equal to or higher than 1 ng/ml. The data in the charts are given in relation to two THC concentration ranges: 1.0–2.5 ng/ml and above 2.5 ng/ml (the value proposed as the limit of the state “after use” and “under the influence” of THC) and in relation to concentration ranges based on the THC elimination curve in human serum. The study did not distinguish between chronic or acute participants and occasional participants.</div> <div>It was based on THC and THCCOOH concentrations. The analyzes were performed using the enzyme-linked immunosorbent method (ELISA) and confirmatory methods such as liquid and gas chromatography coupled with mass spectrometry, in which the limit of quantification of 1 ng/ml was in accordance with the applicable requirement contained in the Regulation of the Minister of Health of July 16, 2014 on the list of similarly acting agents to alcohol and the conditions and method of conducting tests for their presence in the body.</div>

1. Agrawal, A., Neale, M., Prescott, C., Kendler, K. (2004). A twin study of early cannabis use and subsequent use and abuse/dependence of other illicit drugs. Psychological Medicine, 34, 1227–1237. https://doi.org/10.1017/S0033291704002545

2. Blows, S., Ivers, R. Q., Connor, J., Ameratunga, S., Woodward, M., Norton, R. (2005). Marijuana use and car crash injury. Addiction, 100, 605–611. https://doi.org/10.1111/j.1360-0443.2005.01100.x

3. Bondallaz, P., Chtioui, H., Favrat, B., Fornari, E., Giroud, C., Maeder, P. (2017). Assessment of cannabis acute effects on driving skills: laboratory, simulator, and on-road studies. Handbook of Cannabis and Related Pathologies, 379–390. https://doi.org/10.1016/B978-0-12-800756-3.00045-4

4. Bondallaz, P., Favrat, B., Chtioui, H., Fornari, E., Maeder, P., Giroud, C. (2016). Cannabis and its effects on driving skills. Forensic Science International, 268, 92–102. https://doi.org/10.1016/j.forsciint.2016.09.007

5. Broyd, S. J., Greenwood, L. M., Croft, R. J., Dalecki, A., Todd, J., Michie, P. T. Johnstone, S. J., Solowij, N. (2013). Chronic effects of cannabis on sensory gating. International Journal of Psychophysiology, 89, 381–389, https://doi.org/10.1016/j.ijpsycho.2013.04.015

6. Busardò, F. P., Pichini, S., Pellegrini, M., Montana, A., Lo Faro, A. F., Zaami, S., Graziano, S. (2018). Correlation between blood and oral fluid psychoactive drug concentrations and cognitive impairment in driving under the influence of drugs. Current Neuropharmacology, 16, 84–96, https://doi.org/10.2174/1570159X15666170828162057

7. Ćwiklińska, M., Teresiński, G., Buszewicz, G. (2015). Medyczno-sądowe oraz prawno-karne aspekty opiniowania i orzekania w przypadkach intoksykacji środkami odurzającymi i działającymi podobnie do etanolu. Archiwum Medycyny Sądowej i Kryminologii, 65(2), 77–89. https://doi.org/10.5114/amsik.2015.53224

8. DRUID (2022). Meta-analysis of empirical studies concerning the effects of medicines and illegal drugs including pharmacokinetics on safe driving. Project No. TRE N-05-FP6TR-S07.61320-518404-DRUID. Retrieved December 10, 2023 from: https://www.bast.de/Druid/EN/deliverales-list/deliverables-list-node.html

9. Fergusson, D., Boden, J. (2008). Cannabis use and later life outcomes. Addiction, 103, 969–976. doi: 10.1111/j.1360-0443.2008.02221.x

10. Fergusson, D. M. Horwood, L. J. (2001). Cannabis use and traffic accidents in a birth cohort of young adults. Accident Analysis & Prevention, 33, 703–711. https://doi.org/10.1016/S0001-4575(00)00082-8

11. Gieroń, J., Adamowicz, P., Gil, D., Tokarczyk, B., Skulska, A., Lechowicz, W. (2013). Interpretacja wyników oznaczania THC oraz THCCOO H we krwi kierowców – dane z praktyki IES z lat 2010–2013 i projektu DRIUD. (In) M. Kała, D. Zuba (Eds.), XXX Konferencja Toksykologów Sądowych. Materiały konferencyjne (pp. 19–20). Kraków: Wydawnictwo IE S.

12. Gil, D. (2022). Factors affecting the psychomotor ability of drivers and road safety with respect to legal regulations and NGO guidelines. Problems of Forensic Sciences, 132, 259–269. DOI 10.4467/12307483PFS.22.014.17687

13. Hartley, S., Simon, N., Larabi, A., Vaugier, I., Barbot, F., Quera-Salva, M. A., Alvarez, J. C. (2019). Effect of smoked cannabis on vigilance and accident risk using simulated driving in occasional and chronic users and the pharmacokinetic-pharmacodynamic relationship. Clinical Chemistry, 65, 684–693. https://doi.org/10.1373/clinchem.2018.299727

14. Hartman, R. L., Brown, T. L., Milavetz, G., Spurgin, A., Pierce, R. S., Gorelick, D. A., Gaffney, G., Huestis M. A. (2015). Cannabis effects on driving lateral control with and without alcohol. Drug and Alcohol Dependence, 154, 25–37. DOI: 10.1016/j.drugalcdep.2015.06.015

15. Huestis, M. A., Henningfield, J. E., Cone, E. J. (1992). Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. Journal of Analytical Toxicology, 16(5), 276–282. doi: 10.1093/jat/16.5.276

16. Kała, M., Wilk, D., Wójcikiewicz, J. (Eds.) (2017). Ekspertyza sądowa. Zagadnienia wybrane, wydanie 3. Warszawa: Wolters Kluwer.

17. Lechowicz, W., Adamowicz, P., Bakalarz, D., Gil, D., Gieroń, J., Skulska, A., Tokarczyk, B. (2017). Estimating the change in concentration of THC in the blood of drivers over the time between stopping and collection of blood for testing. Problems of Forensic Sciences, 110, 97–109.

18. Lechowicz, W., Gieroń, J. (2022). Correlation of symptoms registered during blood collection from drivers who tested positive for Δ9-tetrahydrocannabinol (THC). Problems of Forensic Sciences, 130/131, 157–168. DOI 10.4467/12307483PFS.22.009.16818

19. Mann, R. E., Adlaf, E., Zhao, J., Stoduto, G., Ialomiteanu, A., Smart, R. G., Asbridge, M. (2007). Cannabis use and self-reported collisions in a representative sample of adult drivers. Journal of Safety Research, 38, 669–674. https://doi.org/10.1016/j.jsr.2007.09.004

20. Marconi, A., Di Forti, M., Lewis, C. M., Murray, R. M., Vassos, E. (2016). Meta-analysis of the association between the level of cannabis use and risk of psychosis. Schizophrenia Bulletin, 42(5), 1262–1269. https://doi.org/10.1093/schbul/sbw003

21. McLaren, J., Mattick, R. P. (2007). Cannabis use in Australia. Use, supply, harms, and responses. Monograph No. 57. Sydney: National Drug and Alcohol Research Centre.

22. Moore, T., Zammit, S., Lingford-Hughes, A., Barnes, T., Jones, P., Burke, M., Lewis, G. (2007). Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet, 370, 319–328. DOI : 10.1016/S0140-6736(07)61162-3

23. Olla, P., Rykulski, N., Hurtubise, J. L., Bartol, S., Foote, R ., Cutler, L., Erdodi, L. A. (2021). Short-term effects of cannabis consumption on cognitive performance in medical cannabis patients. Applied Neuropsychology: Adult, 28(6), 647–657.

24. Preuss, U. W., Huestis, M. A., Schneider, M., Hermann, D., Lutz, B., Hasan, A., Kambeitz, J., Wong, J. W. M., Hoch, E. (2021). Cannabis use and car crashes: a review. Frontiers in Psychiatry, 12, 643315. DOI : 10.1080/23279095.2019.1681424

25. Ramaekers, J. G., Berghaus, G., van Laar, M., Drummer, O. (2004). Dose related risk of motor vehicle crashes after cannabis use. Drug and Alcohol Dependence, 73, 109–119. DOI : 10.1016/j.drugalcdep.2003.10.008

26. Ramaekers, J. G., Mason, N. L., Kloft, L., Theunissen, E. L. (2021). The why behind the high: determinants of neurocognition during acute cannabis exposure. Nature Review Neuroscience, 22(7), 439–454. DOI: 10.1038/s41583-021-00466-4

27. Ramaekers, J. G., Kauert, G., Theunissen, E. L., Toennes, S. W., Moeller, M. R. (2009). Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users. Journal of Psychopharmacology, 23, 266–277. DOI : 10.1177/0269881108092393

28. Ramaekers, J. G., Moeller, M. R., van Ruitenbeek, P., Theunissen, E. L., Schneider, E., Kauert, G. (2006). Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment. Drug and Alcohol Dependance, 85(2), 114–122. DOI: 10.1016/j.drugalcdep.2006.03.015

29. Rozporządzenie Ministra Zdrowia z dnia 16 lipca 2014 r. w sprawie wykazu środków działających podobnie do alkoholu oraz warunków i sposobu przeprowadzania badań na ich obecność w organizmie (2014). Dziennik Ustaw, 948.

30. Spindle, T. R., Martin, E. L., Grabenauer, M., Woodward, T., Milburn, M. A., Vandrey, R. (2021). Assessment of cognitive and psychomotor impairment, subjective effects, and blood THC concentrations following acute administration of oral and vaporized cannabis. Journal of Psychopharmacology, 35(7), 786–803. doi:10.1177/02698811211021583